This work is licensed under a . Your use of this

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this
material constitutes acceptance of that license and the conditions of use of materials on this site.
Copyright 2015, The Johns Hopkins University and Michael Trush. All rights reserved. Use of these materials
permitted only in accordance with license rights granted. Materials provided “AS IS”; no representations or
warranties provided. User assumes all responsibility for use, and all liability related thereto, and must independently
review all materials for accuracy and efficacy. May contain materials owned by others. User is responsible for
obtaining permissions for use from third parties as needed.
1
Section C
Factors Involved in the Toxicity of Nanoparticles
! The material in this video is subject to the copyright of the owners of the material and is being provided for educational purposes under
rules of fair use for registered students in this course only. No additional copies of the copyrighted work may be made or distributed.
Physiochemical Determinants of Particle Toxicity
! The widely accepted physicochemical determinants in
traditional particle toxicology are:
- The form of the particle: for example, fibers more
potent toxicant than isometric particles; spiky fractured
crystals more potent than smooth round-ish particles)
- The chemical composition and related surface
reactivity: free radical-generating surface sites, poorly
coordinated and easily removable metal ions, strong
adsorption and modification of endogenous
antioxidants or of proteins
- The time of residence in a given body compartment
generally defined as biopersistence—a property
related to both chemical factors, such as solubility,
adsorption potential, and to the cellular and tissue
response to it
3
Physiochemical Properties Relevant to
Nanoparticle Toxicity
! Nanosize
- Surprisingly, the smaller the particle, the greater the
toxicity!
! Extremely large specific surface (that is, surface exposed
per unit mass)
! High ratio of surface to bulk atoms, leading to higher
surface reactivity
! Specific reactivity arising at the nanolevel
! Chemical structure linked to nanosize (absence of any
larger counterpart)
! Strong interparticle forces leading to aggregation
4
Possible Components in a Carbon Nanotube
Sample
5
Chemical Reactivity on the Surface of
Nanoparticles
6
Toxicokinetics
! Toxicokinetics: considerations for the biodistribution of
nanoparticles
- How do we best characterize “internal dose” and
“biologically effective dose?”
- Half-lives have been determined in animal models for
some nanoparticles
- Physiological barriers exist
! Such as opsinization and subsequent clearance
by the liver
- Anatomical barriers exist
! Such as tissue epithelium (can nanoparticles
penetrate the epithelium?)
7
Toxicokinetics
! Toxicokinetics: considerations for the biodistribution of
nanoparticles
- Cellular uptake processes: pinocytosis and
phagocytosis
! Other transport mechanisms?
- Is there localization to specific tissues?
- Ability to enter the central nervous system
! Penetrate the blood-brain barrier?
! Olfactory nerve endings
8
Distribution of Nanoparticles in Experimental
Animals
The biodistribution of 40% C18PGA particles coated with 0.1% polysorbate 80 three
hours after injection into mice (open columns) and rats (filled columns). [40% C18PGA
poly (glycerol adipate) with 40% of pendant hydroxyl groups substituted with C18 acyl
groups.]
9
Hazard Assessment
! Some considerations for the toxicodynamics of
nanomaterials
- Nanoparticles have been shown to enter cells in
culture as well as intact organisms
- In a variety of in vitro systems, the following have been
observed
! Cytotoxicity
! Genotoxicity
! Altered gene expression
- What do these observations mean?
- How should they be used to develop practical
toxicological screening methods?
10
Hazard Assessment
! Some considerations for the toxicodynamics of
nanomaterials
- What underlying biologic mechanisms drive
nanomaterial-induced toxicity?
- What adverse health outcomes should we measure (at
the sub-cellular, cellular, organ-system, and organism
levels)?
- What role does synergism play?
! It is likely that nanomaterials will adsorb other
chemicals or biological agents, and these
combinations could behave in novel ways
11
NM Effects as the Basis for Pathophysiology
and Toxicity
Source: (2006). Science. 311: 622,
2006.
12
Man-Made Nanoparticles
! Mechanistically, are man-made nanoparticles similar to
particles derived from combustion?
13
Issues Relevant for Human Toxicology and
Epidemiology
! What are the relevant patterns and pathways of human
exposure to man-made nanomaterials?
! How should we best characterize “exposure,” and what
analytic methods need to be developed and validated to
do so?
! What are the most relevant adverse human health
consequences?
! What prospective cohorts of potentially exposed persons
should be identified (prior to exposure) and monitored
over time following exposure?
14
Putting Nanomaterials into the Toxicological
Paradigm
15
Lecture Evaluation
Please take a moment to
evaluate this lecture. Your
feedback is very important and will
be used for future revisions. The
Evaluation link is available on the
lecture page.
16